Riding the M&A Wave: What February’s 230 HSR Transactions Reveal About Economic Trends and Risk Management
Complex Discovery
MARCH 12, 2025
Healthcare and Pharma Consolidation: With regulatory shifts and technological advancements in biotech, pharmaceutical mergers are increasing, driven by both innovation and cost-saving incentives. Poor governance can also lead to litigation risks if sensitive data is mismanaged. The solution?
52 
Let's personalize your content